Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Underutilized seeds like jackfruit, Indian almond, and tamarind have valuable nutrients and compounds that can be used sustainably in various industries.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

ESR2 gene linked to female-pattern hair loss.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Hair transplant surgery is the most effective, safe, and satisfying treatment for hair loss.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Gut microbiota may significantly influence polycystic ovary syndrome.

Depressed teens have different steroid levels in urine, which may help identify and treat them.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.